Skip to content

Gibopsy

Active
Private limited companyfounded 20241 yr activeCharleroise Steenweg 133, 1060 Sint-Gillis (bij-Brussel), BelgiumKBO/BCE: BE 1014.717.493
Summary

Gibopsy has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €67,592 and a net result of €65,192. Its solvency ranks better than 66% of 2422 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

What they do
Specialist medical practice
NACE 86220
1 site
How big
€88,028total assets 2025
Equity
€67,592
Profit
€65,192
Turnover not published (abridged schema)
Financially healthy?
96 Excellent Checked score 2025
Bankruptcy chance 12 m
0.2%
Who decides
Accounts filed 28 d late0 of 1 deed read
Why 96- Higher-failure-rate region- Young company+ Lower-failure-rate sector+ Annual accounts: healthy financial profileFiled after the deadlineShow the evidence

Checked score

Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6,000 at 30 days only on tighter terms
Liquidity ample (current ratio 4.31; short-term debt: 23.2% and cash: 98.9% of total assets), and 23.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
76.8%
Return on assets
74.1%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
28 d late
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…

Financials

Fiscal year 2025Total assets €88,028Profit €65,192Solvency 76.8%Liquidity 4.31
Total assets
€88,028
2025
Net result
€65,192
2025
Equity
€67,592
2025
Solvency
76.8%
2025

Financials · fiscal year 2025, abbreviated schema

Trend over the years1 fiscal year

Turnover and EBIT margin not published: the abbreviated schema does not require them.

Result and balance sheet2025
Balance-sheet composition
Equity and liabilities €88,028
Equity €67,592
Debt €20,436
Debt finances 23.2% of the balance-sheet total.
Key figures and ratios2025
Key figures and ratios
2025 value
Current ratio
4.31
Debt to equity
0.30
ROE
96.4%
ROA
74.1%
Debt ≤ 1 year
€20,436
Income taxes
€17,383

Peer companies

Historical observation

Of the 11,280 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 97% are still going.

  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
2.6% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 11,280 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Filed annual accountsfiscal year 2025
Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 26 lines
Balance sheet Code2025
Assets
Total assets20/58€88,028
Current assets29/58€88,028
Amounts receivable within one year40/41€1,000
Other amounts receivable41€1,000
Cash at bank and in hand54/58€87,028
Equity and liabilities
Total equity and liabilities10/49€88,028
Equity10/15€67,592
Contributions10/11€2,400
Profit (loss) carried forward14€65,192
Amounts payable17/49€20,436
Amounts payable within one year42/48€20,436
Trade debts44€76
Suppliers440/4€76
Taxes, remuneration and social security45€11,833
Taxes450/3€11,833
Other amounts payable47/48€8,527
Income statement Code2025
Other operating charges640/8€382
Gross operating margin9900€83,120
Operating profit (loss)9901€82,738
Financial charges65/66B€163
Recurring financial charges65€163
Profit (loss) for the period before taxes9903€82,575
Income taxes67/77€17,383
Profit (loss) for the period9904€65,192
Profit (loss) for the period to be appropriated9905€65,192
Appropriation of the result
Profit (loss) to be appropriated9906€65,192

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Other operating charges640/8€382
Gross operating margin9900€83,120
Operating profit (loss)9901€82,738
Financial charges65/66B€163
Recurring financial charges65€163
Profit (loss) for the period before taxes9903€82,575
Income taxes67/77€17,383
Profit (loss) for the period9904€65,192
Profit (loss) for the period to be appropriated9905€65,192
Line2025
Assets
Total assets20/58€88,028
Current assets29/58€88,028
Amounts receivable within one year40/41€1,000
Other amounts receivable41€1,000
Cash at bank and in hand54/58€87,028
Equity and liabilities
Total equity and liabilities10/49€88,028
Equity10/15€67,592
Contributions10/11€2,400
Profit (loss) carried forward14€65,192
Amounts payable17/49€20,436
Amounts payable within one year42/48€20,436
Trade debts44€76
Suppliers440/4€76
Taxes, remuneration and social security45€11,833
Taxes450/3€11,833
Other amounts payable47/48€8,527
Line2025
Profit (loss) for the period9904€65,192
Operating cash flow (approximation)€65,192

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Comparable companies5

Timeline

1 eventLatest 28-08-2026

History

Gibopsy was incorporated on 7 October 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Acts, filings and financial milestones

2026
28-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 28 days late
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Company details

Private limited company · founded 07-10-2024Year ends 31-12Peppol reachable1 site

Register details

Identification
Legal formPrivate limited company
Founded07-10-2024
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
82990Other business support services
86995Nutrition and dietetics services
E-invoicing
Reachable via Peppol
Peppol ID 0208:1014717493
Registered 10-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Sites & property

Location & real-estate footprint
Registered office, Sint-Gillis (bij-Brussel) · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
1,008 m²
Building footprint
882 m²
Volume, LiDAR
12,058 m³
Parcel 21013B0346/00X006, Brussels · tallest building 28.7 m, ±2 floors. Linked by address, not a title deed.
7 companies at this address See who is registered here
1 establishment unit
Gibopsy
Charleroise Steenweg 133, 1060 Sint-Gillis (bij-Brussel)Other business support services
since 2024unit no. 2.364.824.762
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21013B0346/00X006 Brussels 1,008 m² 1 · 882 m² 28.7 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.